LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 22 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,748,686 | -37.7% | 2,113,073 | -17.8% | 0.00% | -50.0% |
| Q2 2023 | $18,857,612 | -17.3% | 2,569,157 | -55.7% | 0.00% | +100.0% |
| Q1 2023 | $22,797,082 | +552.9% | 5,800,784 | +425.0% | 0.00% | – |
| Q4 2022 | $3,491,497 | +5.3% | 1,104,904 | +23.9% | 0.00% | – |
| Q3 2022 | $3,316,000 | +20.4% | 891,500 | -0.0% | 0.00% | – |
| Q2 2022 | $2,755,000 | -49.4% | 891,506 | -15.0% | 0.00% | – |
| Q1 2022 | $5,445,000 | -25.8% | 1,048,962 | -30.8% | 0.00% | -100.0% |
| Q4 2021 | $7,336,000 | -51.2% | 1,515,583 | -10.3% | 0.00% | 0.0% |
| Q3 2021 | $15,048,000 | -19.0% | 1,688,821 | -17.1% | 0.00% | 0.0% |
| Q2 2021 | $18,585,000 | -42.9% | 2,037,831 | +2.2% | 0.00% | -66.7% |
| Q1 2021 | $32,528,000 | – | 1,993,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |